GAO: GAO releases study that says ‘there is no scientific basis’ for the Aarp supplement
AARP says it plans to sue the Food and Drug Administration for allowing the supplement to be sold in pharmacies without prescription.
The agency says the company has “not met its burden to demonstrate that the product is safe and effective for the intended use of consumers.”
The Aarp Supplement was introduced in 2007 and sold in the U.S. as an “anti-oxidant, anti-inflammatory and anti-depressant.”
It is also sold in Europe, Asia and Africa.
In a statement, AARP said it has been informed that the agency plans to seek legal remedies against the company.”AARP stands ready to defend the right of the American people to obtain and use a safe and efficacious supplement that has been approved by the FDA and has been safely marketed for decades,” the statement said.
“The supplement industry should be free to operate as they see fit.”
The FDA did not immediately respond to a request for comment.